封面
市场调查报告书
商品编码
1378700

介入性肿瘤消融市场:按技术、按适应症、按最终用户、按地区

Interventional Oncology Ablation Market, By Technology, By Indication, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 389 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球介入性肿瘤消融市场预计到 2023 年将达到 5.337 亿美元,预测期内(2023-2030 年)年复合成长率为 8.7%。

报告范围 报告详情
基准年 2022年 2023年市场规模 5.337 亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 8.70% 2030年市场规模预测 9.595 亿美元
图 1. 2023 年按技术分類的介入性肿瘤消融的全球市场占有率(%)
介入性肿瘤消融市场-IMG1

介入性肿瘤消融涉及用于局部癌症治疗的微创、影像引导程序。消融技术主要有两种:热消融和非热消融。热疗,例如射频消融 (RFA)、微波消融和冷冻消融,使用热能或冷能来破坏癌细胞。 RFA利用高频电流产生热量并诱发肿瘤凝固性坏死。它广泛用于治疗肝、肾、肺和骨肿瘤。微波消融利用电磁微波搅拌水分子并产生摩擦热来消融组织。冷冻消融透过冷却探针施加极低的温度来冷冻并破坏病灶组织。非热方法包括不可逆电穿孔,它应用短电脉衝在细胞膜上产生奈米孔,导致细胞凋亡。消融治疗微创、恢復快、副作用少、可重复。非常适合无法手术的癌症、不适合手术的患者以及转移性/復发性肿瘤。持续的进展集中在提高消融区域的尺寸和精度。高强度聚焦超音波消融、动态疗法和奈米粒子介导的消融等新兴技术也显示出扩大介入性肿瘤治疗的前景。

市场动态

市场上癌症患者的不断增加预计将推动预测期内全球介入性肿瘤消融市场的成长。例如,根据美国临床肿瘤学会(ASCO)发布的资料,到2023年2月,美国将有超过380万名女性患有或未患有乳癌。 2023年,美国将有297,790名女性被诊断出患有侵袭性乳癌,55,720名女性将被诊断出患有原位乳癌,43,700名女性将死于乳癌(预计有43,170名女性和530名男性)。

本研究的主要特点

  • 本报告对全球介入性肿瘤消融市场进行了详细分析,并列出了以2022年为基准年的预测期(2023-2030年)的市场规模和年复合成长率。
  • 它还揭示了各个细分市场的潜在商机,并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数,介绍了全球介入性肿瘤消融治疗市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 全球介入性肿瘤消融市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球介入性肿瘤消融市场的各种策略矩阵来促进他们的决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第3章市场动态、法规及趋势分析

    • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
    • 影响分析
    • 最近测试启动
    • 流行病学
    • 合併、收购和合作
    • 法规场景
    • 主要进展
    • PEST分析

第4章全球介入性肿瘤消融市场-COVID-19影响分析

    • 经济影响
    • 新型冠状病毒感染疾病(COVID-19)的流行病学
    • 对需求和供给的影响

第5章2018-2030年全球介入性肿瘤消融市场(依技术)

  • 射频消融术
  • 微波消融
  • 冷冻
  • 不可逆电穿孔消融

第6章2018-2030年全球介入性肿瘤消融市场(依适应症)

  • 肝癌
  • 肾癌
  • 肺癌
  • 其他的

第7章全球介入性肿瘤消融市场,依最终用户划分,2018-2030

  • 医院和诊所
  • 门诊手术中心
  • 其他的

第8章2018-2030年全球介入性肿瘤消融市场(按地区)

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • 公司简介
    • Boston Scientific Corporation
    • Johnson &Johnson
    • Medtronic Plc
    • Varian Medical Systems, Inc.
    • EDAP TMS SA
    • AngioDynamics
    • CASCINATION AG
    • Merit Medical Systems, Inc.
    • STARmed Co.
    • Biomedical Srl

第10章章

  • 参考
  • 调查方法
简介目录
Product Code: CMI4445

The global interventional oncology ablation market is estimated to be valued at US$ 533.7 Million in 2023 and is expected to exhibit a CAGR of 8.7% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 533.7 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.70% 2030 Value Projection: US$ 959.5 Mn
Figure 1. Global Interventional Oncology Ablation Market Share (%), By Technology, 2023
Interventional Oncology Ablation Market - IMG1

Interventional oncology ablation involves minimally invasive, image-guided procedures to deliver localized cancer treatment. There are two main types of ablation techniques: thermal and non-thermal. Thermal techniques like radiofrequency ablation (RFA), microwave ablation, and cryoablation use heat or cold energy to destroy cancer cells. RFA uses high-frequency electrical currents to generate heat and induce tumor coagulation necrosis. It is widely used for treating liver, kidney, lung, and bone tumors. Microwave ablation applies electromagnetic microwaves to agitate water molecules and produce frictional heat to ablate tissue. Cryoablation freezes and destroys diseased tissue by applying extremely cold temperatures through cooled probes. Non-thermal techniques include irreversible electroporation, which applies short electric pulses to form nanopores in cell membranes, leading to apoptosis. Ablation therapies are minimally invasive, allow for quicker recovery, have fewer side effects, and can be performed repeatedly. They are ideal for inoperable cancers, patients unfit for surgery, and metastatic or recurrent tumors. Ongoing advances focus on improving ablation zone size and precision. Emerging techniques like high-intensity focused ultrasound ablation, photodynamic therapy, and nanoparticle-mediated ablation also show promise in expanding interventional oncology treatment.

Market Dynamics

The constantly increasing number of cancer patients in the market is expected to drive growth of the global interventional oncology ablation market over the forecast period. For instance, in February 2023, according to data published by the American Society of Clinical Oncology (ASCO), there were more than 3.8 million women living with or beyond breast cancer in the U.S. In 2023, an estimated 297,790 women in the U. S. will be diagnosed with invasive breast cancer, 55,720 women will be diagnosed with non-invasive (in situ) breast cancer, and 43,700 deaths (43,170 women and 530 men) from breast cancer will occur in the U.S.

Key features of the study:

  • This report provides an in-depth analysis of the global interventional oncology ablation market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global interventional oncology ablation market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc., STARmed Co., and Biomedical Srl.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global interventional oncology ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional oncology ablation market

Interventional Oncology Ablation Market Detailed Segmentation:

  • By Technology:
    • Radiofrequency Ablation
    • Microwave Ablation
    • Cryoablation
    • Irreversible Electroporation Ablation
  • By Indication:
    • Liver Cancer
    • Kidney Cancer
    • Lung Cancer
    • Others
  • By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Boston Scientific Corporation
    • Johnson & Johnson
    • Medtronic Plc
    • Varian Medical Systems, Inc.
    • EDAP TMS S.A.
    • AngioDynamics
    • CASCINATION AG
    • Merit Medical Systems, Inc.
    • STARmed Co.
    • Biomedical Srl.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Indication
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis

4. Global Interventional Oncology Ablation Market - COVID-19 Impact Analysis

    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand

5. Global Interventional Oncology Ablation Market, By Technology, 2018- 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Radiofrequency Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Mn)
    • Segment Trends
  • Microwave Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Cryoablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Irreversible Electroporation Ablation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends

6. Global Interventional Oncology Ablation Market, By Indication, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Liver Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Kidney Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Lung Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
    • Segment Trends

7. Global Interventional Oncology Ablation Market, By End User, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospitals & Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Interventional Oncology Ablation Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Boston Scientific Corporation*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Medtronic Plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Varian Medical Systems, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • EDAP TMS S.A.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • AngioDynamics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • CASCINATION AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Merit Medical Systems, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • STARmed Co.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Biomedical Srl
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact